Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
59
days
Immunoglobulins as replacement therapy in hematological malignancies: from historical hypogammaglobulinemia to the era of T-cell-engaging therapies
Authors
Andrea Duminuco; Laura Anastasia Caruso; Rossella Garro; Chiara Finocchiaro; Annalisa Santisi; Arianna Sbriglione; Alessandro Petronaci; Francesco Di Raimondo; Giuseppe Alberto PalumboShow moreShow less
Affiliations
1. University of Catania; 2. A.O.U. Policlinico “G.Rodolico-San Marco”Show moreShow less
46
days
Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes
Authors
Kendra Sweet; Srinivas Tantravahi; Paras Jain; Dan DouerShow moreShow less
Affiliations
1. University of South Florida Morsani College of Medicine, Moffitt Cancer Center, Magnolia Campus; 2. Huntsman Cancer Institute; 3. Azurity Pharmaceuticals Inc., Hyderabad, India; 4. University of Southern California, Keck School of Medicine, LA General Medical CenterShow moreShow less
71
days
Supporting leukemia patients when the real-world gets in the way: improving adherence to oral treatment
Authors
Lindsey Davis; Solomon Ayehu; Benyam MulunehShow moreShow less
Affiliations
1. The University of North Carolina at Chapel Hill Eshelman School of PharmacyShow moreShow less
59
days
Refining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches
Authors
Alessia Moioli; Enrico Carazzai; Ilaria Mion; Matilde Paluzzi; Maria Elena Carazzolo; Francesca Maria Quaglia; Carlo ViscoShow moreShow less
Affiliations
1. Centro Ricerche Cliniche di Verona srl; 2. University of VeronaShow moreShow less
62
days
Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?
Authors
Bartosz Puła; Wiktoria Ryżewska; Artur Handziuk; Agata Tyczyńska; Tadeusz KubickiShow moreShow less
Affiliations
1. Copernicus Memorial Hospital; 2. Medical University of Łódź; 3. Poznań University of Medical Sciences; 4. University Clinical Center Gdansk, Medical University of GdańskShow moreShow less
355
days
Association between the lactate dehydrogenase-to-albumin ratio and prognosis in ICU sepsis-induced coagulopathy patients
Authors
Yufeng Jin; Dong He; Yulong XueShow moreShow less
Affiliations
1. SICU, the First Affiliated Hospital of Xi’an Jiaotong UniversityShow moreShow less
FAQ
How long does Expert Review of Hematology take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Expert Review of Hematology. The fastest paper went from submission to acceptance in 35 days (Myelofibrosis treatment sequencing: mutation-informed risk and optimal JAK inhibitor discontinuation, received 2026-05-05, accepted 2026-06-09); the slowest took 355 days. The average is 151.9 days and the median is 82.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
